Characterization of signaling pathways of P(2Y) and P(2U) purinoceptors in bovine pulmonary artery endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 192-199

  Chen, B C ^a   Lee, C M ^b   Lee, Y T ^b   Lin, Wan Wan ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ca2+ mobilization; P2 Receptor subtypes; Phosphoinositide turnover; Pulmonary artery endothelial cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PURINE RECEPTOR; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; COW; DOSE RESPONSE; ENDOTHELIUM CELL; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULMONARY ARTERY;

ANIMALS; CALCIUM; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOLS; PULMONARY ARTERY; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE; TETRADECANOYLPHORBOL ACETATE; VIRULENCE FACTORS, BORDETELLA;

EID: 0029763536     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00003     Document Type: Article

References (38)

1. Fredholm BB, Abbracchio MP, Burnstock G, et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994;46:143-56.
2. 2-Purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 1995;35:541-79.
3. 2x purinoceptors be classified pharmacologically? Trends Pharmacol Sci 1995;16: 168-74.
4. 2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta. Eur J Pharmacol 1985;108:295-9.
5. 2 Purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol Sci 1990;1134-7.
6. O'Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 1991;12:137-41.
7. 2U receptors in inositol phosphate response. Circ Res 1993; 72:504-10.
8. 2Y-purinoceptors and nucleotide receptors linked to phospholipase C. Br J Pharmacol 1993;108:689-93.
9. 2+ release in bovine adrenal chromaffin and endothelial cells. Pflugers Arch 1994;426:524-33.
10. 2+ mobilization by a nucleotide receptor in glomerular endothelial cells. Am J Physiol 1994;266:F210-7.
11. 2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and inositol phosphate response. Mol Pharmacol 1990;38:84-91
12. Purkiss JR, West D, Wilkes LC, et al. Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists. Br J Pharmacol 1994;111:1041-6.
13. Vigne P, Feolde E, Breittmayer JP, Frelin C. Characterization of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells: similarities to ADP and differences from ATP. Br J Pharmacol 1994;112:775-80.
14. 2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate. J Med Chem 1993;36:3937-46.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
16. Goetz K, Da Prada M, Pletscher A. Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther 1971; 178:210-5.
17. Keppler D, Rudiger J, Decker K. Enzymatic determination of uracil nucleotides in tissues. Anal Biochem 1970;38: 105-14.
18. 2-purinoceptors. Nucleosides Nucleotides 1991;10:1019-28.
19. Cusack NJ, Hourani SMO. Specific but non competitive inhibition by 2-alkylthio analogues of adenosine 5′-monophosphate and adenosine 5′-triphosphate of human platelet aggregation induced by adenosine 5′-diphosphate. Br J Pharmacol 1982;75:397-400.
20. 4-tetraphosphate are present and releasable, but metabolically inactive in human platelets. Biochem J 1982; 208:737-42.
21. P5A-in bovine adrenal medulla: presence in chromaffin granules. J Neurochem 1988;51: 1696-703.
22. Kristhal OA, Marchenko SM, Obukhov AG, Volkova TM. Receptors for ATP in rat sensory neurones: the structure-function relationship for ligands. Br J Pharmacol 1988;95: 1057-62.
23. 2Y site. Br J Pharmacol 1991;103:1980-4.
24. Hoyle CHV. Pharmacological activity of adenine dinucleotides in the periphery: possible receptor classes and transmitter function. Gen Pharmacol 1990;21:827-31.
25. Crack BE, Pollard CE, Beukers MW, et al. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 1995;114:475-81.
26. 2-purinoceptors in C2C12 myotubes. Br J Pharmacol 1993;110:747-52.
27. 6 glioma cells. J Pharmacol Exp Ther 1994;269: 926-31.
28. 2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin. J Pharmacol Exp Ther 1994;268:881-7.
29. 2Y-purinoceptors. Br J Pharmacol 1994;113:614-20.
30. 2x-purinoceptor. Br J Pharmacol 1987;90:383-91.
31. Connoly GP, Harrison PJ. Reactive blue 2 discriminates between responses medicated by UTP and those evoked by ATP or α,β-methylene-ATP on rat sympathetic ganglia. Eur J Pharmacol 1994;259:95-9.
32. Nishizuka T. Studies and perspectives of protein kinase C. Science 1986;233:305-12.
33. Orellana S, Solski PA, Brown JH. Guanosine 5′-0-(thiotriphosphate)-dependent inositol triphosphate formation in membranes is inhibited by phorbol ester and protein kinase C. J Biol Chem 1987;262:1638-43.
34. Katada T, Gilman AG, Watanabe Y, Bauer S, Jakobs K.H. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition. Eur J Biochem 1985;151:431-7.
35. Zick Y, Sagi-Eisenberg K, Piner M, Gierschik P, Spiegel AM. Multisite phosphorylation of the a subunit of transductin by the insulin receptor kinase and protein kinase C. Proc Natl Acad Sci USA 1986;83:9294-7.
36. 2Y-purinoceptors and nucleotide receptor on bovine aortic endothelial cells. Br J Pharmacol 1994;111:723-8.
37. 2U purinoceptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. Circ Res 1995;76:191-8.
38. 2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 1994;91:3275-9.